Leveraging collaborative partnerships to drive transformative advancements in Follicular Lymphoma research
We are dedicated to advancing our mission to find a cure for Follicular Lymphoma (FL) by selectively funding the most promising public and private initiatives. Our approach uniquely blends grant funding with venture investing, enabling us to stimulate scientific breakthroughs and convert these advancements into impactful solutions for FL patients.
Positioned at the forefront of cutting-edge academic science, we play a pivotal role in transforming advanced research into practical biotechnological innovations. This process is strengthened by the insights and expertise of our scientific advisory board, comprising distinguished experts from both academia and industry. Their guidance is crucial in shaping and refining our strategic direction, ensuring that our initiatives are both scientifically sound and aligned with the latest advancements in the field.
Thank you for your interest in contacting us. Please fill out the form with your inquiry or feedback, and our team will promptly respond to assist you.